Yifeng Pharmacy (603939) — Cash Flow-to-Debt Ratio
Yifeng Pharmacy (603939) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥641.93 Million could theoretically repay 0% of its total liabilities (CN¥14.41 Billion) in one year. See financial agility of Yifeng Pharmacy to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yifeng Pharmacy Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Yifeng Pharmacy across 14 annual periods. For the full cash flow conversion analysis, see Yifeng Pharmacy cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Yifeng Pharmacy (2011–2024)
Year-by-year debt coverage analysis for Yifeng Pharmacy. Check 603939 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | CN¥4.22 Billion | CN¥16.58 Billion | ▼ -25.3% |
| 2023 | 0.34x | CN¥4.66 Billion | CN¥13.69 Billion | ▲ +3.6% |
| 2022 | 0.33x | CN¥3.92 Billion | CN¥11.92 Billion | ▲ +40.6% |
| 2021 | 0.23x | CN¥2.15 Billion | CN¥9.19 Billion | ▲ +25.6% |
| 2020 | 0.19x | CN¥1.34 Billion | CN¥7.17 Billion | ▼ -13.6% |
| 2019 | 0.22x | CN¥963.23 Million | CN¥4.47 Billion | ▲ +56.2% |
| 2018 | 0.14x | CN¥510.71 Million | CN¥3.70 Billion | ▼ -30.2% |
| 2017 | 0.20x | CN¥317.20 Million | CN¥1.60 Billion | ▲ +76.2% |
| 2016 | 0.11x | CN¥139.94 Million | CN¥1.25 Billion | ▼ -37.1% |
| 2015 | 0.18x | CN¥181.52 Million | CN¥1.02 Billion | ▼ -44.9% |
| 2014 | 0.32x | CN¥212.35 Million | CN¥655.19 Million | ▲ +8.4% |
| 2013 | 0.30x | CN¥156.71 Million | CN¥524.21 Million | ▲ +55.4% |
| 2012 | 0.19x | CN¥80.73 Million | CN¥419.63 Million | ▼ -23.8% |
| 2011 | 0.25x | CN¥122.99 Million | CN¥487.12 Million | — |